29
Cellid
299660.KQ·KOSDAQSeoul KRFounded 201660 employees
Micro CapbiotechPublicInfectious DiseaseOncology
Platform: CeliVax neoAg
Market Cap
$0.05B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (299660.KQ)
Loading 299660.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 299-6118 | 299-6118 | Phase 1/2 | 2 | MET | Melanoma | ||
| Tixalucimab | 299-2876 | Phase 1/2 | 1 | MALT1 | CML |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
Cellid trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)